Piramal Pharma Ltd. — filings
Every filing on record for this company. Each row opens the document it names.
| Filing | Period | Scope / kind | Filed | Document |
|---|---|---|---|---|
| Results XBRL (NSE) | 2022-09-30 | Standalone | — | INDAS_854422_6941_10112022165302_WEB.xml |
| Results XBRL (NSE) | 2022-09-30 | Consolidated | — | INDAS_854434_6941_10112022165349_WEB.xml |
| Results XBRL (NSE) | 2022-12-31 | Standalone | — | INDAS_89090_789310_09022023123946.xml |
| Results XBRL (NSE) | 2022-12-31 | Consolidated | — | INDAS_89091_789314_09022023124053.xml |
| Results XBRL (NSE) | 2023-03-31 | Standalone | — | INDAS_92612_851834_25052023034953.xml |
| Results XBRL (NSE) | 2023-03-31 | Consolidated | — | INDAS_92615_851845_25052023035236.xml |
| Results XBRL (NSE) | 2023-06-30 | Consolidated | — | INDAS_95272_907677_03082023092949.xml |
| Results XBRL (NSE) | 2023-06-30 | Standalone | — | INDAS_95273_907680_03082023093140.xml |
| Results XBRL (NSE) | 2023-09-30 | Standalone | — | INDAS_98159_970125_28102023044125.xml |
| Results XBRL (NSE) | 2023-09-30 | Consolidated | — | INDAS_98161_970133_28102023044311.xml |
| Results XBRL (NSE) | 2023-12-31 | Standalone | — | INDAS_101798_1039652_30012024091308.xml |
| Results XBRL (NSE) | 2023-12-31 | Consolidated | — | INDAS_101799_1039657_30012024091425.xml |
| Results XBRL (NSE) | 2024-03-31 | Standalone | — | INDAS_105677_1120742_10052024092259.xml |
| Results XBRL (NSE) | 2024-03-31 | Consolidated | — | INDAS_105678_1120745_10052024092427.xml |
| Results XBRL (NSE) | 2024-06-30 | Standalone | — | INDAS_109533_1203138_26072024125922.xml |
| Results XBRL (NSE) | 2024-06-30 | Consolidated | — | INDAS_109536_1203146_26072024010031.xml |
| Results XBRL (NSE) | 2024-09-30 | Standalone | — | INDAS_113140_1286528_23102024082726.xml |
| Results XBRL (NSE) | 2024-09-30 | Consolidated | — | INDAS_113141_1286531_23102024082948.xml |
| Results XBRL (NSE) | 2024-12-31 | Standalone | — | INDAS_117924_1363798_28012025090302.xml |
| Results XBRL (NSE) | 2024-12-31 | Consolidated | — | INDAS_117925_1363802_28012025090457.xml |
| Results XBRL (NSE) | 2025-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1439217_14052025 |
| Results XBRL (NSE) | 2025-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1439218_14052025 |
| Results XBRL (NSE) | 2025-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1495855_28072025 |
| Results XBRL (NSE) | 2025-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1495857_28072025 |
| Results XBRL (NSE) | 2025-09-30 | Standalone | — | INTEGRATED_FILING_INDAS_1566229_05112025 |
| Results XBRL (NSE) | 2025-09-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1566230_05112025 |
| Results XBRL (NSE) | 2025-12-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1614519_30012026 |
| Results XBRL (NSE) | 2025-12-31 | Standalone | — | INTEGRATED_FILING_INDAS_1614524_30012026 |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1660700_28042026 |
| Results XBRL (NSE) | 2026-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1660701_28042026 |
| Results XBRL (NSE) | 2026-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1704574_29072026 |
| Results XBRL (NSE) | 2026-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1704575_29072026 |
| Results XBRL (BSE) | 2022-09-30 | Standalone | 2022-11-22T10:13:55 | Main_Ind_As_543635_9112022173242.xml |
| Results XBRL (BSE) | 2022-09-30 | Consolidated | 2022-11-22T10:13:55 | Main_Ind_As_543635_9112022173511.xml |
| Annual report | 2023-03-31 | grade A | 2023-07-06T20:38:35.867 | 73a532ba-6b75-4bf8-a1b1-469e19ecf065.pdf |
| Annual report | 2024-03-31 | grade A | 2024-07-02T15:08:16.72 | c09d72ec-f184-4eba-bcc8-93b26b846609.pdf |
| Annual report | 2025-03-31 | grade A | 2025-07-02T12:52:53.91 | 33c9f38c-0692-4e04-b789-77605f82aa29.pdf |
| Annual report | 2026-03-31 | grade A | 2026-07-03T15:31:30.04 | 8a3aabd8-6aef-45b8-aa20-370bc162321a.pdf |
| Concall | 2022-09-30 | TRANSCRIPT | — | Date_20221111_Piramal Pharma Ltd._Concal_Q2FY23.pdf |
| Concall | 2022-12-31 | TRANSCRIPT | — | Date_20230213_Piramal Pharma Ltd._Concal_Q3FY23.pdf |
| Concall | 2023-03-31 | TRANSCRIPT | — | Date_20230518_Piramal Pharma Ltd._Concal_Q4FY23.pdf |
| Concall | 2023-03-31 | COVER_LETTER | — | Date_20230529_Piramal Pharma Ltd._Concal_Q4FY23.pdf |
| Concall | 2023-06-30 | TRANSCRIPT | — | Date_20230807_Piramal Pharma Ltd._Concal_Q1FY24.pdf |
| Concall | 2023-09-30 | COVER_LETTER | — | Date_20231031_Piramal Pharma Ltd._Concal_Q2FY24.pdf |
| Concall | 2023-12-31 | COVER_LETTER | — | Date_20240202_Piramal Pharma Ltd._Concal_Q3FY24.pdf |
| Concall | 2024-03-31 | COVER_LETTER | — | Date_20240514_Piramal Pharma Ltd._Concal_Q4FY24.pdf |
| Concall | 2024-06-30 | COVER_LETTER | — | Date_20240729_Piramal Pharma Ltd._Concal_Q1FY25.pdf |
| Concall | 2024-09-30 | COVER_LETTER | — | Date_20241026_Piramal Pharma Ltd._Concal_Q2FY25.pdf |
| Concall | 2024-12-31 | COVER_LETTER | — | Date_20250130_Piramal Pharma Ltd._Concal_Q3FY25.pdf |
| Concall | 2025-09-30 | COVER_LETTER | — | Date_20251107_Piramal Pharma Ltd._Concal_Q2FY26.pdf |
| Concall | 2025-12-31 | COVER_LETTER | — | Date_20260130_Piramal Pharma Ltd._Concal_Q3FY26.pdf |
| Concall | 2026-06-30 | COVER_LETTER | — | Date_20260731_Piramal Pharma Ltd._Concal_Q1FY27.pdf |
| Shareholding XBRL | 2022-10-19 | — | — | SHP_173244_744393_03112022042913_WEB.xml |
| Shareholding XBRL | 2022-12-31 | — | — | SHP_175248_775051_20012023033233_WEB.xml |
| Shareholding XBRL | 2023-03-31 | — | — | SHP_177891_829789_21042023121401_WEB.xml |
| Shareholding XBRL | 2023-06-30 | — | — | SHP_179557_891245_18072023080737_WEB.xml |
| Shareholding XBRL | 2023-08-22 | — | — | SHP_180405_922768_25082023015028_WEB.xml |
| Shareholding XBRL | 2023-09-27 | — | — | SHP_180631_941763_06102023052210_WEB.xml |
| Shareholding XBRL | 2023-09-30 | — | — | SHP_182352_959877_19102023021617_WEB.xml |
| Shareholding XBRL | 2023-12-31 | — | — | SHP_185084_1030201_19012024060525_WEB.xm |
| Shareholding XBRL | 2024-03-31 | — | — | SHP_187890_1101499_19042024050025_WEB.xm |
| Shareholding XBRL | 2024-06-30 | — | — | SHP_190316_1194636_19072024041817_WEB.xm |
| Shareholding XBRL | 2024-09-30 | — | — | SHP_192970_1278432_18102024055358_WEB.xm |
| Shareholding XBRL | 2024-12-31 | — | — | SHP_195073_1349012_17012025025839_WEB.xm |
| Shareholding XBRL | 2025-03-31 | — | — | SHP_198690_1420964_21042025023117_WEB.xm |
| Shareholding XBRL | 2025-06-30 | — | — | SHP_1514526_19082025110418_WEB.xml |
| Shareholding XBRL | 2025-09-30 | — | — | SHP_1551721_17102025032408_WEB.xml |
| Shareholding XBRL | 2025-12-31 | — | — | SHP_1605746_20012026045511_WEB.xml |
| Shareholding XBRL | 2026-03-31 | — | — | SHP_1654598_20042026115851_WEB.xml |
| Shareholding XBRL | 2026-06-30 | — | — | SHP_1697240_20072026060616_WEB.xml |
| Related-party XBRL | 2022-09-30 | — | — | RPT_PPLPHARMA_22112022160848.xml |
| Related-party XBRL | 2023-03-31 | — | — | RPT_851417_24052023110601_WEB.xml |
| Related-party XBRL | 2023-09-30 | — | — | RPT_969713_27102023103003_WEB.xml |
| Related-party XBRL | 2024-03-31 | — | — | RPT_1120718_10052024085917_WEB.xml |
| Related-party XBRL | 2024-09-30 | — | — | RPT_1286523_23102024082258_WEB.xml |